Advances in ERAS to Reduce the Incidence of Chronic Post-Surgical Pain and Persistent Postoperative Opioid Use: A Narrative Review.

IF 2.7 4区 医学 Q2 SURGERY
Journal of Investigative Surgery Pub Date : 2026-12-01 Epub Date: 2026-05-15 DOI:10.1080/08941939.2026.2664932
Zhiyou Peng, Pavan Tankha, Zhiying Feng, Jijun Xu
{"title":"Advances in ERAS to Reduce the Incidence of Chronic Post-Surgical Pain and Persistent Postoperative Opioid Use: A Narrative Review.","authors":"Zhiyou Peng, Pavan Tankha, Zhiying Feng, Jijun Xu","doi":"10.1080/08941939.2026.2664932","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic postsurgical pain (CPSP) remains a clinically significant complication following major surgery, contributing to long-term functional impairment, reduced quality of life, and persistent opioid use. Enhanced Recovery After Surgery (ERAS) pathways have transformed perioperative care by integrating multimodal, opioid-sparing strategies to improve acute recovery; however, their effectiveness in preventing CPSP is less clearly defined.</p><p><strong>Methods: </strong>We conducted a narrative review of randomized controlled trials, meta-analyses, cohort studies, and clinical guidelines evaluating perioperative interventions relevant to CPSP prevention, including systemic pharmacologic agents, regional and neuraxial techniques, preemptive analgesia, and early mobilization strategies. Evidence was appraised with respect to acute analgesic efficacy, impact on CPSP incidence, safety, and feasibility within ERAS pathways.</p><p><strong>Results: </strong>Most single-modality interventions demonstrated consistent benefit for acute pain control and opioid reduction, but limited or inconsistent effects on CPSP prevention when used in isolation. Gabapentinoids and neuraxial techniques showed little support for long-term benefit and raised concerns regarding adverse effects and recovery delays. In contrast, multimodal strategies incorporating peripheral and interfascial regional techniques, intravenous lidocaine, duloxetine in select populations, wound infiltration, and early mobilization showed more promising associations with reduced persistent pain, particularly when tailored to patient risk and surgical context. Early mobilization and effective acute pain control emerged as critical, interdependent elements influencing pain chronification.</p><p><strong>Conclusions: </strong>Current evidence does not support reliance on any single perioperative intervention to prevent CPSP. Instead, prevention appears to require a comprehensive, mechanism-based, and patient-centered ERAS approach integrating preoperative risk stratification, multimodal pharmacotherapy, targeted regional techniques, and early functional recovery.</p>","PeriodicalId":16200,"journal":{"name":"Journal of Investigative Surgery","volume":"39 1","pages":"2664932"},"PeriodicalIF":2.7000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Investigative Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/08941939.2026.2664932","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic postsurgical pain (CPSP) remains a clinically significant complication following major surgery, contributing to long-term functional impairment, reduced quality of life, and persistent opioid use. Enhanced Recovery After Surgery (ERAS) pathways have transformed perioperative care by integrating multimodal, opioid-sparing strategies to improve acute recovery; however, their effectiveness in preventing CPSP is less clearly defined.

Methods: We conducted a narrative review of randomized controlled trials, meta-analyses, cohort studies, and clinical guidelines evaluating perioperative interventions relevant to CPSP prevention, including systemic pharmacologic agents, regional and neuraxial techniques, preemptive analgesia, and early mobilization strategies. Evidence was appraised with respect to acute analgesic efficacy, impact on CPSP incidence, safety, and feasibility within ERAS pathways.

Results: Most single-modality interventions demonstrated consistent benefit for acute pain control and opioid reduction, but limited or inconsistent effects on CPSP prevention when used in isolation. Gabapentinoids and neuraxial techniques showed little support for long-term benefit and raised concerns regarding adverse effects and recovery delays. In contrast, multimodal strategies incorporating peripheral and interfascial regional techniques, intravenous lidocaine, duloxetine in select populations, wound infiltration, and early mobilization showed more promising associations with reduced persistent pain, particularly when tailored to patient risk and surgical context. Early mobilization and effective acute pain control emerged as critical, interdependent elements influencing pain chronification.

Conclusions: Current evidence does not support reliance on any single perioperative intervention to prevent CPSP. Instead, prevention appears to require a comprehensive, mechanism-based, and patient-centered ERAS approach integrating preoperative risk stratification, multimodal pharmacotherapy, targeted regional techniques, and early functional recovery.

ERAS在减少术后慢性疼痛和术后持续阿片类药物使用方面的进展:一项叙述性综述。
背景:慢性术后疼痛(CPSP)仍然是大手术后临床重要的并发症,导致长期功能障碍、生活质量下降和持续使用阿片类药物。增强术后恢复(ERAS)途径通过整合多模式、阿片类药物节约策略来改善急性恢复,从而改变了围手术期护理;然而,它们在预防CPSP方面的有效性尚不明确。方法:我们对随机对照试验、荟萃分析、队列研究和临床指南进行了叙述性回顾,以评估与CPSP预防相关的围手术期干预措施,包括全身药物、区域和神经轴技术、先发制人的镇痛和早期动员策略。对急性镇痛疗效、对CPSP发生率的影响、安全性和ERAS通路内可行性的证据进行了评价。结果:大多数单模态干预在急性疼痛控制和阿片类药物减少方面表现出一致的益处,但在单独使用时对CPSP预防的影响有限或不一致。加巴喷丁类药物和轴向技术的长期疗效支持不足,并引起了对不良反应和恢复延迟的担忧。相比之下,结合外周和界面区域技术、静脉注射利多卡因、在特定人群中使用度洛西汀、伤口浸润和早期活动的多模式策略显示出更有希望减少持续性疼痛,特别是在根据患者风险和手术情况量身定制时。早期活动和有效的急性疼痛控制成为影响疼痛慢性化的关键、相互依赖的因素。结论:目前的证据不支持依赖任何单一的围手术期干预来预防CPSP。相反,预防似乎需要一个全面的、以机制为基础的、以患者为中心的ERAS方法,包括术前风险分层、多模式药物治疗、有针对性的区域技术和早期功能恢复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.20
自引率
0.00%
发文量
114
审稿时长
6-12 weeks
期刊介绍: Journal of Investigative Surgery publishes peer-reviewed scientific articles for the advancement of surgery, to the ultimate benefit of patient care and rehabilitation. It is the only journal that encompasses the individual and collaborative efforts of scientists in human and veterinary medicine, dentistry, basic and applied sciences, engineering, and law and ethics. The journal is dedicated to the publication of outstanding articles of interest to the surgical research community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书